Embed Size (px)
Citation preview
The OxyPhone®
Pediatric Nebulizer
Phone
Sept 2011 Version
20-30 million children world-wide Treated in home with multiple nebs daily Most common reason to visit a pediatric ER
1.71 million children under age 5 in USA 1.5 million office visits for kids under 5 169,000 ER visits 27,400 Hospitalizations
*Summary Health Statistics for U.S. Children: National Health Interview Survey, 2010 Asthma Prevalence, Health Care Use, and Mortality: United States, 2005–2009 Pediatric Emergency Care, 05/18/2010. Knapp JF et al
Asthma
2% of children develop croup annually Most of those children are 1 to 2 years old 3,077,000 provider contacts /year* 317,000 ER visits/year 41,000 croup hospitalizations/year
* Pediatric Hospitalizations for Croup (Laryngotracheobronchitis): Biennial Increases Associated with Human Parainfluenza Virus 1 Epidemics: CDC
*Pediatric Emergency Care, 05/18/2010. Knapp JF et al
Croup
Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection (LRTI) in young children worldwide
Almost 100% of children have RSV by age 2
149,000 Hospitalizations/year 1.7 million office visits in children<5 years 228,000 emergency room visits 236,000 hospital outpatient visits
*Pharmacoeconomics. 2004: Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases
Pediatric Emergency Care, 05/18/2010. Knapp JF et al
RSV (bronchiolitis)
Home
Office Hospital
ER Totals
Asthma
1.714 millio
n
1.5 millio
n
27,400 169,000
3.410 million
Croup 3.08 millio
n
41,000 317,000
3.438 million
RSV 1.7 millio
n
149,000
464,000
2.313 million
Total of Patients
1.714 millio
n
6.28 millio
n
217,400
950,000
9.161Millio
n
Summary of Respiratory Diseases in Children Under Age 5
Claim: A mask is the best way to give breathing treatments to children
The Problem
►Reality: The mask frightens many children.
Claim: A mask is best to deliver medication
Reality: Studies show that the Oxyphone and blow-by work better than a mask in kids
◦ Restrepo: Inhaled drug mass was greater with T-piece than with a standard pediatric aerosol mask under the conditions studied. [Respir Care 2006;51(1):56–61.]
◦ Geller: Blowby vs face mask for nebulized drugs in young children. (JACI, 113, Issue 2 (supplement) Feb 2004)
◦ Geller: The Oxyphone with was equal to conventional BB (Summary report: In vitro analysis of Oxyphone aerosol delivery)
◦ Geller: The Oxyphone with the mouthpiece 4 cm from the mouth of the model exceeded the performance of a close-fitting mask. (In vitro analysis of the Singing Arrow Oxyphone delivery system, 4 April 2007)
Aerosol Myths
Claim: Crying increases inhalation of medication from nebulizer
Reality: Crying decreases droplet deposition to 25% of that with normal respiratory activity.*
Reality: Crying increases the anxiety of the child and parent, increasing respiratory rate and pulse.
Reality: Crying decreases the I:E ratio, thus increasing the dead space in the mask
Aerosol Myths
* R Iles, et al, Arch Dis Child 1999;81:163-165 ( August)
The Oxyphone Pediatric Nebulizer Phone
Familiar Shape
Plays music
Easy to use
Works better than a mask
The Solution
Uses music to soothe the child
Telephone shape is familiar to most kids
Works better than a mask with increased delivery of medication in 3-5 micron size*
Adapts to the child’s position of comfort
Cleanable, reusable and Latex-free
OxyPhone
*Geller: Oxyphone vs Mask, in vitro study, 2007
Battery Version for Health Care Providers
Plays pre-recorded music
Music stops after 10 minutes
Batteries last 40-50 treatments
Adjusts automatically to child’s position of comfort
Reusable, cleanable, disposable
Latex-free
Attaches to most nebulizer acorns
Home Version
Plugs into child’s favorite music on MP3, CD, IPOD or similar
Automatically adjusts to child’s position of comfort
Reusable and cleanable
Latex-free
Attaches to most nebulizer acorns
50 treatments/unit, cost less than ¢50/neb
More effective delivery of active particle size means shorter, more efficacious treatments
No need to hold child down, freeing a member of the team to perform other duties
Happier parents and kids, less screaming and crying, more compliance, less aggravation for all
Benefits for Providers
Supporting Studies “The Oxyphone, with the mouthpiece about 4
cm from the mouth of the model, exceeded the performance of a close-fitting mask.”
Oxyphone Mask on Face
Mask at 2cm
FPD %* 7.6 % 1.2 4.6 % 0.3 2.2 % 0.9
*FPD %: The FPD (Fine Particle Dose) expressed as percent of nominal dose
Summary Report: In vitro analysis of the Singing Arrow Oxyphone Delivery System and VixOne Disposable Nebulizer with Unit Dose Albuterol (2.5mg/3ml)
Oxyphone Interview in ER
Click on Picture to
Play
Live video, NOT rehearsed
Notice child denied the mask treatment
BUT
Welcomed the OxyPhone with no hesitation
Less resistance = less time and anxiety
*Key Points*
HCS Designation is A7005 (NU) Covered by private insurance May be distributed from private office
without prior authorization (If have DME License)
Defined by HCS as Durable Medical Equipment
Allows replacement minimum of 2/year
Insurance Information
Listed with FDA as CCQ (Nebulizer, Medicinal, non-ventilatory (atomizer))
Insured through Singing Arrow, LLC for $2000000
Studies on file Manufactured in Hong Kong by Newtec
International, LTD, an ISO 9001 certified company
Packaged in USA US Patent 5,803,063
Information
Home Unit: Packed in plastic bag withnebulizer acorn, 7’ connector and instructions
Battery Unit: Packed in plastic bag with nebulizer acorn, 7’ connector and instructions
Bulk Unit: For Health Providers: Cases of 24 with volume discount
Package Options
Registered in North Carolina as an LLC
Corporate Office:◦ PO Box 2290◦ Davidson, NC 28036◦ www.oxyphone.com◦ 704-564-8064◦ FAX: 704-896-1815
Carol Corey, President: [email protected] Craig Corey, MD, VP R&D:
Singing Arrow, LLC
Vocals and Flute:◦ Melissa Corey
Background: ◦ Rick Hinkle
◦ Susan Bennett
Melody & Lyrics: ◦ Dr. Craig Corey
Music
Now Playing ”The Oxyphone Song”: Pre-recorded onto the Battery Version (2 minutes)
